DOH Memo 2012 0154 addresses inclusion of which condition in urine screening?

DOH Memo 2012 0154 addresses inclusion of which condition in urine screening?

• A. MSUD
• B. PKU
• C. SCD
• D. G6PD deficiency

Answer: (A)

This question tests which metabolic disorder DOH memo 2012-0154 adds to urine-based newborn screening. Maple syrup urine disease is included because early detection through urine screening enables immediate dietary management to prevent neurodevelopmental damage, aligning with the goal of preventing disability by timely intervention. Other conditions listed are typically addressed by newborn screening through other methods or panels, or are not the focus of this specific urine-screening expansion, so they do not fit the memo’s scope.

This question tests which metabolic disorder DOH memo 2012-0154 adds to urine-based newborn screening. Maple syrup urine disease is included because early detection through urine screening enables immediate dietary management to prevent neurodevelopmental damage, aligning with the goal of preventing disability by timely intervention. Other conditions listed are typically addressed by newborn screening through other methods or panels, or are not the focus of this specific urine-screening expansion, so they do not fit the memo’s scope.